Wednesday, 16 September 2020

Side effect which paused Oxford, AstraZeneca clinical trial 'unlikely' related to COVID-19 vaccine

Oxford says a safety review into why a participant in the COVID-19 vaccine trial developed unexplained neurological symptoms including changed sensation or limb weakness found they were likely not linked to the shot.



No comments:

Post a Comment